Top Markets
Coin of the day
Bioceltix S.a. Bioceltix S.a.

Bioceltix S.a.

BCX
Rank in Stocks #20639
Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals... Bioceltix S.A. engages in the development of stem cell-based biopharmaceuticals for veterinary use. The company’s products include BCX-CM-J, a stem-cell based biological drug for the treatment of osteoarthritis in dogs; BCX-CM-AD, a drug candidate based on allogeneic stem cells for the treatment of atopic dermatitis in dogs; and BCX-EM, a drug candidate based on allogeneic mesenchymal stem cells for the treatment of arthritis in horses. The company was founded in 2016 and is headquartered in Wroclaw, Poland.
Share Price
$22.49
Market Cap
$124.44M
Change (1 day)
0.25%
Change (1 year)
-22.20%
Country
PL
Trade Bioceltix S.a. (BCX)

Category

Dividend yield history for Bioceltix S.a. (BCX)
Bioceltix S.a. (stock symbol: BCX) dividend yield (TTM) as of 2026: 0
Average dividend yield, last 5 years : 0.00%
Dividend yield history for Bioceltix S.a. (BCX) from 2026 to 2026
Dividend Yield at the end of each year (TTM)
Year Dividend Yield Change
Not enough data for the provided dates.
Dividend yields (TTM) for similar companies or competitors
Company Dividend Yield Country
0.00%
US
0.00%
NL
3.12%
AU
0.00%
US
0.00%
CH